A Study of ET-02 in Patients With Relapsed or Refractory B-cell Malignancy(NHL/ALL)
Clinical trial NCT04933825 · UNKNOWN
Trial details
- NCT number
- NCT04933825
- Sponsor
- EdiGene (GuangZhou) Inc.
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-20
- Primary completion
- 2024-09-30
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.